CloudMD Software & Services Inc (OTCPK:DOCRF)

$ 0.0236 0.0018 (8.26%) Market Cap: 8.44 Mil Enterprise Value: 21.93 Mil PE Ratio: 0 PB Ratio: 0.39 GF Score: 0/100

Q3 2023 CloudMD Software & Services Inc Earnings Call Transcript
Nov 30, 2023

$0.09025 (+0.28%)

Earnings
Q2 2023 CloudMD Software & Services Inc Earnings Call Transcript
Aug 28, 2023

$0.10964 (+9.64%)

Earnings
Q1 2023 CloudMD Software & Services Inc Earnings Call Transcript
May 30, 2023

$0.12755 (-5.24%)

Earnings
Q4 2022 CloudMD Software & Services Inc Earnings Call Transcript
Apr 25, 2023

$0.14 (-3.96%)

Earnings
Q3 2022 CloudMD Software & Services Inc Earnings Call Transcript
Nov 15, 2022

$0.175 (-9.54%)

Earnings
Q2 2022 CloudMD Software & Services Inc Earnings Call Transcript
Aug 23, 2022

$0.2848 (-4.11%)

Earnings
Q1 2022 CloudMD Software & Services Inc Earnings Call Transcript
May 31, 2022

$0.3867 (+19.67%)

Earnings
Q4 2021 CloudMD Software & Services Inc Earnings Call Transcript
May 03, 2022

$0.3975 (-6.32%)

Earnings
Q3 2021 CloudMD Software & Services Inc Earnings Call Transcript
Nov 29, 2021

$1.05 (+9.17%)

Earnings
Q2 2021 CloudMD Software & Services Inc Earnings Call Transcript
Aug 25, 2021

$1.49 (+3.11%)

Earnings
Q1 2021 CloudMD Software & Services Inc Earnings Call Transcript
May 27, 2021

$1.54 (-0.19%)

Earnings
CloudMD Software & Services Inc to Acquire Oncidium Inc - Conference Call Transcript
Apr 08, 2021

Q2 2021 CloudMD Software & Services Inc Earnings Call Transcript

Aug 25, 2021 / 09:00PM GMT

Release Date Price: $1.49 (+3.11%)

Transcript

Operator

Good afternoon and welcome to the CloudMD's Second Quarter 2021 Earnings Conference Call and Webinar. My name is Jonathan and I will be your conference facilitator today. As a reminder, this conference call is being recorded. (Operator Instructions).

It is now my pleasure to turn the call over to Julia Becker, Vice President, Investor Relations with opening remarks.

Julia Becker

CloudMD Software & Services Inc. - VP, Investor Relations

Thank you, Jonathan, and good afternoon everyone. Thank you for joining us today, August 25th, 2021, for our second quarter earnings conference call and webinar. We'll start the call with a summary from our CEO, Dr. Essam Hamza, followed by our President, Karen Adams, to provide commentary on our Digital Health Services and Enterprise Health Solutions division. Our Chief Financial Officer, Dan Lee, will then recap the company's second quarter 2021 financial results before opening up for question and answer period from our covering analysts.

A friendly reminder that today's discussion contains certain

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.